JMI Syringes & Medical Devices (DHA:JMISMDL) Cyclically Adjusted Revenue per Share: BDT95.35 (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DHA:JMISMDL JMI Syringes & Medical Devices Ltd DHA:JMISMDL
75 GF Score
Price BDT146.30
View Full Analysis

What is JMI Syringes & Medical Devices Cyclically Adjusted Revenue per Share?

JMI Syringes & Medical Devices DHA:JMISMDL +3.25% 75 Cyclically Adjusted Revenue per Share is BDT95.35 as of Mar. 2025. GuruFocus rates DHA:JMISMDL with a GF Score™ of 75/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

JMI Syringes & Medical Devices's adjusted revenue per share for the three months ended in Mar. 2025 was BDT12.007. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is BDT95.35 for the trailing ten years ended in Mar. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2026-07-29), JMI Syringes & Medical Devices's current stock price is BDT146.30. JMI Syringes & Medical Devices's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was BDT95.35. JMI Syringes & Medical Devices's Cyclically Adjusted PS Ratio of today is 1.53.


JMI Syringes & Medical Devices  (DHA:JMISMDL) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

JMI Syringes & Medical Devices's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=146.30/95.35
=1.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


JMI Syringes & Medical Devices Cyclically Adjusted Revenue per Share Related Terms


JMI Syringes & Medical Devices Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for JMI Syringes & Medical Devices's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

JMI Syringes & Medical Devices Cyclically Adjusted Revenue per Share Chart

JMI Syringes & Medical Devices Annual Data
Trend Dec15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 97.46 96.56

JMI Syringes & Medical Devices Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.79 96.56 95.68 95.01 95.35

DHA:JMISMDL vs ISRG, BDX, MDLN: Cyclically Adjusted Revenue per Share Comparison

For the Medical Instruments & Supplies subindustry, JMI Syringes & Medical Devices's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


JMI Syringes & Medical Devices Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, JMI Syringes & Medical Devices's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where JMI Syringes & Medical Devices's Cyclically Adjusted PS Ratio falls into.


DHA:JMISMDL
75GF Score
JMI Syringes & Medical Devices Ltd DHA:JMISMDL
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

JMI Syringes & Medical Devices Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, JMI Syringes & Medical Devices's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=12.007/319.7990*319.7990
=12.007

Current CPI (Mar. 2025) = 319.7990.

JMI Syringes & Medical Devices Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 30.326 238.638 40.640
201509 20.974 237.945 28.189
201512 14.043 236.525 18.987
201603 18.881 238.132 25.356
201606 36.931 241.018 49.003
201609 16.386 241.428 21.705
201612 22.444 241.432 29.729
201703 26.879 243.801 35.258
201706 25.439 244.955 33.212
201709 19.989 246.819 25.899
201712 21.030 246.524 27.281
201803 32.323 249.554 41.421
201806 21.676 251.989 27.509
201809 23.097 252.439 29.260
201812 23.065 251.233 29.360
201903 35.672 254.202 44.877
201906 18.458 256.143 23.045
201909 13.230 256.759 16.478
201912 13.480 256.974 16.776
202003 17.475 258.115 21.651
202006 21.471 257.797 26.635
202009 9.992 260.280 12.277
202012 18.686 260.474 22.942
202103 17.420 264.877 21.032
202106 20.217 271.696 23.796
202109 12.580 274.310 14.666
202112 19.069 278.802 21.873
202203 21.227 287.504 23.611
202206 28.271 296.311 30.512
202209 13.546 296.808 14.595
202212 15.968 296.797 17.206
202303 14.947 301.836 15.837
202306 13.874 305.109 14.542
202309 14.383 307.789 14.944
202312 16.016 306.746 16.698
202403 13.940 312.332 14.273
202406 16.369 314.175 16.662
202409 15.406 315.301 15.626
202412 17.866 315.605 18.103
202503 12.007 319.799 12.007

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of BDT95.35 mean?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a Cyclically Adjusted Revenue per Share of BDT95.35 as of Mar. 2025. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on JMI Syringes & Medical Devices and its competitors.
Is JMI Syringes & Medical Devices' Cyclically Adjusted Revenue per Share too high?
JMI Syringes & Medical Devices' current Cyclically Adjusted Revenue per Share is BDT95.35. Overall, JMI Syringes & Medical Devices has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does JMI Syringes & Medical Devices' Cyclically Adjusted Revenue per Share compare to ISRG and BDX?
JMI Syringes & Medical Devices' Cyclically Adjusted Revenue per Share of BDT95.35 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Revenue per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on JMI Syringes & Medical Devices and its competitors. JMI Syringes & Medical Devices's current Cyclically Adjusted Revenue per Share is BDT95.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMI Syringes & Medical Devices stock overvalued right now?
JMI Syringes & Medical Devices (DHA:JMISMDL) has a current Cyclically Adjusted Revenue per Share of BDT95.35. The current Cyclically Adjusted Revenue per Share is BDT95.35. JMI Syringes & Medical Devices' overall GF Score™ is 75/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For JMI Syringes & Medical Devices (DHA:JMISMDL), the current Cyclically Adjusted Revenue per Share is BDT95.35 as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

JMI Syringes & Medical Devices Business Description

Address 117, Kazi Nazrul Islam Avenue, Unique Heights, Level-11, Ramna, Dhaka, BGD, 1217
JMI Syringes & Medical Devices Ltd is a Bangladesh-based syringe and medical device manufacturing company. It manufactures and markets disposable syringe, auto-disable syringe, needle, infusion set, scalp vein set, urine drainage bag, insulin syringe, First AID bandage, riles tube, IV Cannula, feeding tube, and Blood Lancets, and other products.
75GF Score

Get the complete analysis for DHA:JMISMDL

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

BDT146.30
Price